Risk Factors for Carbapenem-Resistant Enterobacteriaceae Colonization and the Effect on Clinical Outcomes and Prognosis in Allogeneic Hematopoietic Stem Cell Transplanted Patients

References

• Isles NS, Mu A, Kwong JC, Howden BP, Stinear TP. Gut microbiome signatures and host colonization with multidrug-resistant bacteria. Trends Microbiol. 2022;30(9):853–865. doi:10.1016/j.tim.2022.01.013
   PubMed Web of Science ®Google Scholar
• Cao W, Zhang J, Bian Z, et al. Active Screening of Intestinal Colonization of Carbapenem-Resistant Enterobacteriaceae for Subsequent Bloodstream Infection in Allogeneic Hematopoietic Stem Cell Transplantation. Infect Drug Resist. 2022;15:5993–6006. doi:10.2147/IDR.S387615
   PubMed Web of Science ®Google Scholar
• Trecarichi EM, Pagano L, Candoni A, et al. Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey. Clin Microbiol Infect. 2015;21(4):337–343. doi:10.1016/j.cmi.2014.11.022
   PubMed Web of Science ®Google Scholar
• Micozzi A, Gentile G, Minotti C, et al. Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias. BMC Infect Dis. 2017;17(1):203. doi:10.1186/s12879-017-2297-9
   PubMed Web of Science ®Google Scholar
• Meletis G. Carbapenem resistance: overview of the problem and future perspectives. Therapeutic Advances Infectious Dis. 2016;3(1):15–21. doi:10.1177/2049936115621709
   PubMed Web of Science ®Google Scholar
• Misch EA, Andes DR. Bacterial Infections in the Stem Cell Transplant Recipient and Hematologic Malignancy Patient. Infect Dis Clin North Am. 2019;33(2):399–445. doi:10.1016/j.idc.2019.02.011
   PubMed Web of Science ®Google Scholar
• Trecarichi EM, Pagano L, Martino B, et al. Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey. Am J Hematol. 2016;91(11):1076–1081. doi:10.1002/ajh.24489
   PubMed Web of Science ®Google Scholar
• de Molla VC, Heidrich V, Bruno JS, et al. Disruption of the oral microbiota is associated with a higher risk of relapse after allogeneic hematopoietic stem cell transplantation. Sci Rep. 2021;11(1):17552.
   PubMed Web of Science ®Google Scholar
• Heidrich V, Bruno JS, Knebel FH, et al. Dental Biofilm Microbiota Dysbiosis Is Associated With the Risk of Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol. 2021;12:692225. doi:10.3389/fimmu.2021.692225
   PubMedGoogle Scholar
• Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59–65. doi:10.1038/nature08821
   PubMed Web of Science ®Google Scholar
• Su F, Luo Y, Yu J, et al. Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review. Eur J Med Res. 2021;26(1):37. doi:10.1186/s40001-021-00508-8
   PubMed Web of Science ®Google Scholar
• Shono Y, van den Brink MRM. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation. Nat Rev Cancer. 2018;18(5):283–295. doi:10.1038/nrc.2018.10
   PubMed Web of Science ®Google Scholar
• Kim S, Covington A, Pamer EG. The intestinal microbiota: antibiotics, colonization resistance, and enteric pathogens. Immunol Rev. 2017;279(1):90–105. doi:10.1111/imr.12563
   PubMed Web of Science ®Google Scholar
• Chong PP, Koh AY. The gut microbiota in transplant patients. Blood Rev. 2020;39:100614. doi:10.1016/j.blre.2019.100614
   PubMed Web of Science ®Google Scholar
• Logan LK, Weinstein RA. The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: the Impact and Evolution of a Global Menace. J Infect Dis. 2017;215(suppl_1):S28–S36. doi:10.1093/infdis/jiw282
   PubMed Web of Science ®Google Scholar
• Tang SSL, Chee E, Teo JQ, Chlebicki MP, Kwa ALH. Incidence of a subsequent carbapenem-resistant Enterobacteriaceae infection after previous colonisation or infection: a prospective cohort study. Int J Antimicrob Agents. 2021;57(6):106340. doi:10.1016/j.ijantimicag.2021.106340
   PubMed Web of Science ®Google Scholar
• Satlin MJ, Jenkins SG, Walsh TJ. The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies. Clin Infect Dis. 2014;58(9):1274–1283. doi:10.1093/cid/ciu052
   PubMed Web of Science ®Google Scholar
• Song JY, Jeong IS. Development of a risk prediction model of carbapenem-resistant Enterobacteriaceae colonization among patients in intensive care units. Am J Infect Control. 2018;46(11):1240–1244. doi:10.1016/j.ajic.2018.05.001
   PubMed Web of Science ®Google Scholar
• Liu J, Zhang H, Feng D, et al. Development of a Risk Prediction Model of Subsequent Bloodstream Infection After Carbapenem-Resistant Enterobacteriaceae Isolated from Perianal Swabs in Hematological Patients. Infect Drug Resist. 2023;16:1297–1312. doi:10.2147/IDR.S400939
   PubMed Web of Science ®Google Scholar
• Clark O, Lyman G, Castro AA, Clark L, Djulbegovic B. Colony stimulating factors for chemotherapy induced febrile neutropenia. Cochrane Database Systematic Rev. 2003;3(3):CD003039.
   Google Scholar
• van Vliet MJ, Harmsen HJM, de Bont ESJM, Tissing WJE. The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog. 2010;6(5):e1000879. doi:10.1371/journal.ppat.1000879
   PubMed Web of Science ®Google Scholar
• Sonis ST. The pathobiology of mucositis. Nat Rev Cancer. 2004;4(4):277–284. doi:10.1038/nrc1318
   PubMed Web of Science ®Google Scholar
• Taur Y, Jenq RR, Perales M-A, et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood. 2014;124(7):1174–1182. doi:10.1182/blood-2014-02-554725
   PubMed Web of Science ®Google Scholar
• Org E, Mehrabian M, Parks BW, et al. Sex differences and hormonal effects on gut microbiota composition in mice. Gut Microbes. 2016;7(4):313–322. doi:10.1080/19490976.2016.1203502
   PubMed Web of Science ®Google Scholar
• Bilinski J, Robak K, Peric Z, et al. Impact of Gut Colonization by Antibiotic-Resistant Bacteria on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation: a Retrospective, Single-Center Study. Biol Blood Marrow Transplant. 2016;22(6):1087–1093. doi:10.1016/j.bbmt.2016.02.009
   PubMed Web of Science ®Google Scholar
• Haro C, Rangel-Zúñiga OA, Alcalá-Díaz JF, et al. Intestinal Microbiota Is Influenced by Gender and Body Mass Index. PLoS One. 2016;11(5):e0154090. doi:10.1371/journal.pone.0154090
   PubMed Web of Science ®Google Scholar
• Tischendorf J, de Avila RA, Safdar N. Risk of infection following colonization with carbapenem-resistant Enterobactericeae: a systematic review. Am J Infect Control. 2016;44(5):539–543. doi:10.1016/j.ajic.2015.12.005
   PubMed Web of Science ®Google Scholar
• Ducarmon QR, Zwittink RD, Hornung BVH, van Schaik W, Young VB, Kuijper EJ. Gut Microbiota and Colonization Resistance against Bacterial Enteric Infection. Microbiol Mol Biol Rev. 2019;83(3). doi:10.1128/MMBR.00007-19
   PubMed Web of Science ®Google Scholar
• Poutsiaka DD, Price LL, Ucuzian A, Chan GW, Miller KB, Snydman DR. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality. Bone Marrow Transplant. 2007;40(1):63–70. doi:10.1038/sj.bmt.1705690
   PubMed Web of Science ®Google Scholar
• Dandoy CE, Haslam D, Lane A, et al. Healthcare Burden, Risk Factors, and Outcomes of Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections after Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016;22(9):1671–1677. doi:10.1016/j.bbmt.2016.06.002
   PubMed Web of Science ®Google Scholar
• Orasch C, Weisser M, Mertz D, et al. Comparison of infectious complications during induction/consolidation chemotherapy versus allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2010;45(3):521–526. doi:10.1038/bmt.2009.187
   PubMed Web of Science ®Google Scholar
• Blennow O, Ljungman P, Sparrelid E, Mattsson J, Remberger M. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations. Transpl Infect Dis. 2014;16(1):106–114. doi:10.1111/tid.12175
   PubMed Web of Science ®Google Scholar
• Ustun C, Young J-AH, Papanicolaou GA, et al. Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2019;54(8):1254–1265. doi:10.1038/s41409-018-0401-4
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Kurosawa S, Tajima K, et al. Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2016;51(4):553–559. doi:10.1038/bmt.2015.330
   PubMed Web of Science ®Google Scholar
• Mikulska M, Del Bono V, Bruzzi P, et al. Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients. Infection. 2012;40(3):271–278. doi:10.1007/s15010-011-0229-y
   PubMed Web of Science ®Google Scholar